Novosanis receives grant from Interreg CrossCare to build a next-generation of its unique and patented intradermal drug delivery device, VAX-ID, in collaboration with living labs Happy...
Timothi Van Mulder will present Novosanis' breakthrough results on the development of a painless injection device for children at 12 th Vaccine Congress in Budapest, Hungary from September...
This website uses cookies to help us give you the best experience when you visit our website. Read our cookie policy to learn more about the cookies we use. By continuing to use this website, you consent to the use of these cookies.
Novosanis
